Published in Head Neck on March 01, 2008
Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila) (2009) 3.70
Oral health and risk for head and neck squamous cell carcinoma: the Carolina Head and Neck Cancer Study. Cancer Causes Control (2010) 1.41
Concern A review of the epidemiology of oral and pharyngeal carcinoma: update. Head Neck Oncol (2012) 1.12
Determinants of head and neck cancer survival by race. Head Neck (2010) 1.03
Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care. Cancer Prev Res (Phila) (2009) 1.02
Polymorphisms in DNA damage response genes and head and neck cancer risk. Biomarkers (2010) 0.98
Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U.S., 1995-2005. PLoS One (2012) 0.97
Estrogen and cytochrome P450 1B1 contribute to both early- and late-stage head and neck carcinogenesis. Cancer Prev Res (Phila) (2012) 0.96
Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment. Otolaryngol Clin North Am (2013) 0.94
Racial differences in the relationship between tobacco, alcohol, and squamous cell carcinoma of the head and neck. Cancer Causes Control (2012) 0.92
Improved survival with HPV among African Americans with oropharyngeal cancer. Clin Cancer Res (2013) 0.90
Public Awareness of Oral and Pharyngeal Cancer: What Can a Dentist Do? Todays FDA (2015) 0.83
Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States--possible role for human papillomavirus in survival disparities. Head Neck (2011) 0.83
The relationships among individual and regional smoking, socioeconomic status, and oral and pharyngeal cancer survival: a mediation analysis. Cancer Med (2015) 0.80
Determinants of First-Time Cancer Examinations in a Rural Community: A Mechanism for Behavior Change. Am J Public Health (2015) 0.79
Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine. Genes Cancer (2016) 0.79
Race and sex disparities in long-term survival of oral and oropharyngeal cancer in the United States. J Cancer Res Clin Oncol (2015) 0.78
The role of oral hygiene in head and neck cancer: results from International Head and Neck Cancer Epidemiology (INHANCE) consortium. Ann Oncol (2016) 0.77
Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center. Head Neck (2015) 0.77
Disparate molecular, histopathology, and clinical factors in head and neck squamous cell carcinoma racial groups. Otolaryngol Head Neck Surg (2012) 0.77
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA (2006) 12.47
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survival: an analysis of the Survival, Epidemiology, and End Results database. Cancer (2012) 3.12
The landscape of recombination in African Americans. Nature (2011) 3.06
Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet (2002) 2.76
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet (2011) 2.70
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium. PLoS Genet (2011) 1.94
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis (2008) 1.64
Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiol Biomarkers Prev (2010) 1.62
Plasma cytokines in women with chronic fatigue syndrome. J Transl Med (2009) 1.55
Prostate cancer risk associated loci in African Americans. Cancer Epidemiol Biomarkers Prev (2009) 1.49
Hypovitaminosis D: a widespread epidemic. Geriatrics (2008) 1.47
Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. PLoS Genet (2011) 1.47
Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans. Hum Mol Genet (2011) 1.45
Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida. Arch Dermatol (2009) 1.42
The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res (2004) 1.41
Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer (2013) 1.37
DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2003) 1.20
DNA damage and breast cancer risk. Carcinogenesis (2003) 1.19
Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. PLoS One (2010) 1.17
Outdoor exercise reduces the risk of hypovitaminosis D in the obese. J Steroid Biochem Mol Biol (2007) 1.15
Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett (2003) 1.13
A genome-wide association study of breast cancer in women of African ancestry. Hum Genet (2012) 1.11
A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma. Head Neck (2005) 1.10
Cytokine genetic polymorphisms and prostate cancer aggressiveness. Carcinogenesis (2009) 1.09
Intake of plant foods and associated nutrients in prostate cancer risk. Nutr Cancer (2009) 1.08
Comparison of stage at diagnosis of melanoma among Hispanic, black, and white patients in Miami-Dade County, Florida. Arch Dermatol (2006) 1.07
Earlier age at menopause, work, and tobacco smoke exposure. Menopause (2008) 1.07
If you take it, it works... J Womens Health (Larchmt) (2014) 1.05
Interactions of cytokine gene polymorphisms in prostate cancer risk. Carcinogenesis (2008) 1.03
Some new food for thought: the role of vitamin D in the mental health of older adults. Curr Psychiatry Rep (2009) 1.03
Comparison of multivariate adaptive regression splines and logistic regression in detecting SNP-SNP interactions and their application in prostate cancer. J Hum Genet (2008) 1.02
Nucleotide-excision repair and prostate cancer risk. Cancer Lett (2005) 1.00
DNA damage levels in prostate cancer cases and controls. Carcinogenesis (2005) 0.98
Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy. Mol Cancer Ther (2003) 0.98
Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy. Urology (2006) 0.97
Polymorphisms in drug metabolism genes, smoking, and p53 mutations in breast cancer. Mol Carcinog (2008) 0.96
Self-reported versus measured height and weight in Hispanic and non-Hispanic menopausal women. J Womens Health (Larchmt) (2011) 0.94
Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome. Behav Brain Funct (2010) 0.94
Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancer. Oncol Rep (2008) 0.92
Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res (2008) 0.91
Analysis of G/A polymorphism in the androgen response element I of the PSA gene and its interactions with the androgen receptor polymorphisms. Urology (2003) 0.90
Phytoestrogens in the prevention of postmenopausal bone loss. J Clin Densitom (2013) 0.90
OGG1 is degraded by calpain following oxidative stress and cisplatin exposure. DNA Repair (Amst) (2008) 0.88
Phytoestrogens for menopausal bone loss and climacteric symptoms. J Steroid Biochem Mol Biol (2012) 0.88
A genome-wide scan for breast cancer risk haplotypes among African American women. PLoS One (2013) 0.87
Salivary markers and risk factor data: a multivariate modeling approach for head and neck squamous cell carcinoma detection. Cancer Biomark (2011) 0.85
Genome-wide association study of age at menarche in African-American women. Hum Mol Genet (2013) 0.85
The role of vitamin D in improving physical performance in the elderly. J Bone Miner Res (2013) 0.84
Menthol cigarette smoking and health, Florida 2007 BRFSS. Am J Health Behav (2010) 0.84
Phytoestrogens and bone health. Curr Opin Endocrinol Diabetes Obes (2010) 0.84
Assembling an orchestra: Fanconi anemia pathway of DNA repair. Front Biosci (Landmark Ed) (2010) 0.83
The potential for enhancing the power of genetic association studies in African Americans through the reuse of existing genotype data. PLoS Genet (2010) 0.83
Pleomorphic adenoma of the trachea. Ear Nose Throat J (2008) 0.82
Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer. Carcinogenesis (2011) 0.82
Bladder cancer clusters in Florida: identifying populations at risk. J Urol (2009) 0.82
Damage-dependent regulation of MUS81-EME1 by Fanconi anemia complementation group A protein. Nucleic Acids Res (2013) 0.81
Sun protection policies in Miami-Dade County public schools: opportunities for skin cancer prevention. Pediatr Dermatol (2005) 0.81
Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma. Head Neck (2011) 0.81
The response of elderly veterans to daily vitamin D3 supplementation of 2,000 IU: a pilot efficacy study. J Am Geriatr Soc (2011) 0.80
Pancreatic cancer clusters and arsenic-contaminated drinking water wells in Florida. BMC Cancer (2013) 0.79
Advanced presentation of melanoma in African Americans: the Miami-Dade County experience. J Am Acad Dermatol (2004) 0.79
A comprehensive analysis of parotid and salivary gland cancer: worse outcomes for male gender. J Surg Res (2010) 0.78
MG132 inhibition of proteasome blocks apoptosis induced by severe DNA damage. Cell Cycle (2011) 0.78
Differences in vitamin D3 dosing regimens in a geriatric community-dwelling population. Endocr Pract (2012) 0.78
Novel innate cancer killing activity in humans. Cancer Cell Int (2011) 0.78
Combined genetic and nutritional risk models of triple negative breast cancer. Nutr Cancer (2014) 0.77
Geographic distribution of melanoma in Miami-Dade County, Florida: online first. Arch Dermatol (2011) 0.77
Characterization of risk factors for adjuvant radiotherapy-associated pain in a tri-racial/ethnic breast cancer population. Pain (2016) 0.76
Validation of the cell cycle G(2) delay assay in assessing ionizing radiation sensitivity and breast cancer risk. Cancer Manag Res (2009) 0.75
F-18 FDG PET/CT in the assessment of recurrent anaplastic T-cell lymphoma of the external auditory canal. Clin Nucl Med (2010) 0.75
Pioneer for nursing: Frances Payne Bolton. Reflect Nurs Leadersh (2003) 0.75
Pathology quiz case 2. Primary intestinal-type sinonasal adenocarcinoma. Arch Otolaryngol Head Neck Surg (2004) 0.75
Pathology quiz case 1. Small cell carcinoma (SmCC) of the parotid gland. Arch Otolaryngol Head Neck Surg (2004) 0.75
Saliva as a diagnostic tool. MLO Med Lab Obs (2015) 0.75
Autosomal dominant hyperostosis/osteosclerosis with high serum alkaline phosphatase activity. J Clin Endocrinol Metab (2003) 0.75